Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Phase III Randomized Controlled Trial Comparing Between Adjuvant Chemotherapy and Observation in High Risk Patients With Completely Resected Stage Ib Lung Adenocarcinoma

NCT02281708 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02281708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02281708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Phase III Randomized Controlled Trial Comparing Between Adjuvant Chemotherapy and Observation in High Risk Patients With Completely Resected Stage Ib Lung Adenocarcinoma
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2014
Completion date
September 30, 2020
Enrollment
1,012 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ib lung carcinoma